Safety of pertussis vaccines for adolescents
https://doi.org/10.22625/2072-6732-2020-12-4-29-36
Abstract
Aim: to investigate the safety of acellular pertussis vaccines for adolescents.
Materials and methods. The clinical tolerability of revaccination against pertussis (cell-free component), diphtheria and tetanus was analyzed in 107 children aged 13,5–14 years. Group 1 consisted of children revaccinated with DTacP-IPV combined vaccine (Tetraxim), group 2 – vaccinated with Td and group 3 – children who received Tdap vaccine (Adacel).
Results. Statistically significant differences in the frequency of local reactions between the group that received Tdap and the other two (DTacP-IPV and Td) were detected (p = 0.001and p = 0.04, respectively). Analysis of the structure of local reactions revealed a difference only in the occurrence of the hyperemia at the site of injection, with the most frequent registration in the groups of children vaccinated with DTacPIPV (29,4%) and Td (14,7%), whereas in patients vaccinated with Tdap – only in 5,9% (χ2 = 6,8 p = 0,03). Systemic reactions occurred with the same frequency in all studied groups and did not require medical correction, as well as local reactions. Thus, revaccination against pertussis, diphtheria and tetanus of adolescents using Tdap, containing the acellular pertussis component, does not exceed the frequency of systemic reactions and the number of local reactions is significantly lower in comparison with the vaccine with a reduced content of diphtheria and tetanus toxoids (Td) that is used in practice for a long time.
About the Authors
M. P. KostinovRussian Federation
Moscow
E. V. Prutskova
Russian Federation
Ulyanovsk
A. P. Cherdantsev
Russian Federation
Ulyanovsk
G. R. Feiskhanova
Russian Federation
Ulyanovsk
A. M. Kostinov
Russian Federation
Moscow
A. E. Vlasenko
Russian Federation
Moscow
V. B. Polishchuk
Russian Federation
Moscow
References
1. Pertussis vaccines: WHO position paper. The Weekly Epidemiological Record. 2015; 35: 433-460. URL: http://www.who.int/wer.
2. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid-=7833e232-c37d-4555-b528-6f9c0df41396&t=
3. New in Clinics, Diagnostics and Vaccine Prevention of Controlled Infections. Ed. M.P. Kostinov. Moscow, Medicine for everybody, 1997. 110 p. (in Russian).
4. Kostinov M.P., Lavrov V.F. New Age Vaccines for Prevention of Infectious Diseases. 2nd ed. Moscow, MDV, 2010. 192 p. (in Russian).
5. Kostinov M.P., Andreeva N.P., Cherdantsev A.P. Infekcionnye bolezni: novosti, mneniya, obuchenie. 2018; 7 (2): 92-7. (in Russian). DOI: 10.24411/2305-3496-2018-12011.
6. Prutskova E.V., Cherdantsev A.P., Andreeva N.P. Infekcionnye bolezni: novosti, mneniya, obuchenie. 2018; 7(2): 71-7. (in Russian). DOI: 10.24411/2305-3496-2018-12008.
7. Prikaz Ministerstva zdravoohraneniya RF ot 21 marta 2014 g. N 125n “Ob utverzhdenii nacional’nogo kalendarya profilakticheskih privivok i kalendarya profilakticheskih privivok po epidemicheskim pokazaniyam” (s izmeneniyami i dopolneniyami 16 iyunya 2016 g., 13 aprelya 2017 g., 19 fevralya 2019 g.). (in Russian). URL: http://docs.cntd.ru/document/499086215.
8. Federal’nyj zakon “Ob immunoprofilaktike infekcionnyh boleznej” ot 17.09.1998 N 157-FZ. (in Russian). URL: http://docs.cntd.ru/document/901717430.
9. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid-=44a26ad8-14fb-4e47-b616-b1cc08458929&t=
10. Sahai H., Khurshid A. Statistics in epidemiology: methods, techniques, and applications. Boca Raton, FL: CRC Press, c 1996. 352 p. ISBN: 0-8493-9444-9.
11. Kenneth J. Rothman. Epidemiology: An Introduction. Oxford University Press, 2002. 240 p. ISBN: 0-10-513554-7.
12. World Health Organization. Global Manual on Surveillance of Adverse Events Following Immunization. Geneva, Switzerland: World Health Organization, 2014. 111 p. ISBN: 978 92 4 150776 9
13. Kostinov M.P. Kliniko-immunologicheskie osobennosti vaktsinatsii AKDS-M i ADS-M preparatami detey s allergicheskimi zabolevaniyami [Clinical and immunological features of DTP-M and DT-M vaccination for children with allergy][abstract of dissertation]. Moscow (Russia): I.I. Mechnikov Research Institute of Vaccines and Sera; 1993. 47 p. (in Russian).
14. Petina O.A., Bolshakova L.N., Leshkevich I.A., Kostinov M.P. Epidemiologiya i infekcionnye bolezni. Aktual’nye voprosy. 2015; 3, 44-9. (in Russian). eLIBRARY ID: 23876253.
15. Tatochenko V.K., Kostinov M.P., Namazova L.S., Fedorov A.M. Epidemiological aspects of whooping cough in the Russian Federation. Features of vaccine prophylaxis in modern conditions: Practical manual for physicians. Moscow, 2005. 38 p. (in Russian). eLIBRARY ID: 24241287
16. Vaccination of children with impaired health. 1st ed. Ed. M.P. Kostinov. Moscow, Medicine for everybody, 1996. 78p. (in Russian).
17. Vaccines and vaccination: national guide. Eds. V.V. Zverev, R.M. Khaitov. Moscow, GEOTAR-Media, 2014. 640 p. (in Russian).
18. Kostinov M.P., Balabolkin I.I., Maksimova N.M., Egor’kov N.A., Gervazieva V.B. Pediatriya. Zhurnal imeni G.N. Speranskogo. 1991; 2: 68–71. (in Russian). eLIBRARY ID: 23669236
19. Kostinov M.P., Gervazieva V.B., Balabolkin I.I., Botvinyeva V.V., Ovsyannikova I.G., Fedorova O.E. Immunologiya. 1991; 5: 56–9. (in Russian).
20. Kostinov M.P., Avanesova E.G., Balabolkin I.I., Maksimova N.M., Sigaeva L.A., Konovalova E.A. Pediatriya. Zhurnal imeni G.N. Speranskogo. 1994; 4: 72–6. (in Russian). eLIBRARY ID: 23669434
21. Kostinov M.P., Balabolkin I.I., Sigaeva L.A., Reutova V.S., Bogatyreva E.Ya. Zhurnal mikrobiologii, epidemiologii i immunologii. 1995; 1: 44–9. (in Russian). eLIBRARY ID: 23669509
22. Allergology and Immunology: national guide. Eds. R.M. Haitov, N.I. Ilyina. M.: GEOTAR-Media, 2014. 656 p. (in Russian).
23. Tarasova A.A., Lukushkina E.F., Kostinov M.P., Afraymovich M.G., Baskakova E.Yu., Kvasova M.A., Akimova V.P. Vaccine prevention. Nizhniy Novgorod. 2016. 103p. (in Russian).
24. Kostinov A.M., Kostinov M.P. Infekciya i immunitet, 2018; 8(3): 284–94. (in Russian). URL: http://dx.doi.org/10.15789/2220-7619-2018-3-251-262 .
25. Boyce TG, Virk A. While waiting for better pertussis vaccines, let’s use the ones we have. J. Infect. Dis. 2015; 211(7): 1196–7. URL: https://doi.org/10.1093/infdis/jiu591.
26. Brady MT, Byington CL, Davies HD, Edwards KM, Jackson MA, Maldonado YA, Murray DL, Orenstein WA, Rathore M., Sawyer M., Schutze GE, Willoughby RE, Zaoutis TE. Recommended childhood and adolescent immunization schedule—United States, 2014, Pediatrics. 2014; 133(2):357–363. URL: https://doi.org/10.1542/peds.2011-3630.
27. Edwards KM, Decker MD Pertussis vaccines. Vaccines, 6th ed. Ed. Plotkin S.A., Orenstein W., Offit P.A. Elsevier Saunders. 2013: 447–492. ISBN: 97814557000905.
28. Recommended immunisations for pertussis in EU countries. Vaccine Schedule. European Centre for Disease Prevention and Control. URL: http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx (01.07.2017)
Review
For citations:
Kostinov M.P., Prutskova E.V., Cherdantsev A.P., Feiskhanova G.R., Kostinov A.M., Vlasenko A.E., Polishchuk V.B. Safety of pertussis vaccines for adolescents. Journal Infectology. 2020;12(4):29-36. (In Russ.) https://doi.org/10.22625/2072-6732-2020-12-4-29-36